Tag: Relief Therapeutics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Relief Therapeutics

NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 ...

Added to Collection on: 2021-03-29 05:03:45

Tags for this article:

Medical specialties
Medicine
Health
Intensive care medicine
Relief Therapeutics
Cycloserine/lurasidone
Aviptadil
Acute respiratory distress syndrome
COVID-19
Angiotensin-converting enzyme 2
Placebo
Mechanical ventilation
RELIEF THERAPEUTICS Holding AG
United States
NeuroRx Inc.

Click the tags to see associated articles and topics

View Article Details
Humanigen, NeuroRx Plan FDA Emergency Use Filings for COVID-19 Candidates

Added to Collection on: 2021-03-30 12:22:30

Tags for this article:

Drugs
Health sciences
Organic compounds
Monoclonal antibodies
Antiviral drugs
COVID-19 drug development
Breakthrough therapy
Orphan drugs
Relief Therapeutics
Bamlanivimab
Baricitinib
Remdesivir

Click the tags to see associated articles and topics

View Article Details
(PRNewsfoto/NeuroRx)

Added to Collection on: 2021-04-06 04:52:30

Tags for this article:

Life Sciences
Health care
Health sciences
Antiviral drugs
Orphan drugs
COVID-19 drug development
Nucleotides
Remdesivir
Relief Therapeutics
Aviptadil
Gilead Sciences
National Institutes of Health
NeuroRx Inc.
RELIEF THERAPEUTICS Holding AG

Click the tags to see associated articles and topics

View Article Details
Relief Provides Update on Progress and Plans with ACER-001 for the Treatment of Urea Cycle ...

Added to Collection on: 2021-05-18 05:03:45

Tags for this article:

Nitrogen cycle
Branches of biology
Chemistry
Physical sciences
Prodrugs
Household chemicals
Urea cycle
Rare diseases
Sodium phenylbutyrate
Relief Therapeutics
Hyperammonemia
Maple syrup urine disease
United States
Vasoactive intestinal peptide
Relief Therapeutics Holdings AG
Acer Therapeutics

Click the tags to see associated articles and topics

View Article Details
Inhaled drug delivery tech company Aerami to go public through SPAC merger - MassDevice

Added to Collection on: 2021-12-08 04:45:15

Tags for this article:

Corporate finance
Private equity
Special-purpose acquisition company
Finance
Life Sciences
Articles
Relief Therapeutics
United Therapeutics
FoxWayne Enterprises Acquisition Corp.

Click the tags to see associated articles and topics

View Article Details
NRx Aims to Bring Zyesami to Market Based on Real-World Data in Treating Seriously Ill ... - BioBuzz

Added to Collection on: 2022-02-15 02:09:11

Tags for this article:

Life Sciences
Health
Occupational safety and health
COVID-19 drug development
Relief Therapeutics
Orphan drugs
Right-to-try law
Remdesivir
Treatment and management of COVID-19
Aviptadil
Gilead Sciences
COVID-19
Jonathan Javitt

Click the tags to see associated articles and topics

View Article Details
Relief Therapeutics Appoints Christopher Wick as Senior Director, Head of U.S. Sales | BioSpace

Added to Collection on: 2022-03-21 10:17:17

Tags for this article:

Life Sciences
Biotechnology
Industry economics)
Relief Therapeutics
Novartis
Alexion Pharmaceuticals
Pharmaceutical industry in China
Aviptadil
Christopher Wick
RELIEF THERAPEUTICS Holding SA
THERAPEUTICS Holding SA
United States

Click the tags to see associated articles and topics

View Article Details
Biotech Stock Roundup: MRNA's Jab Update, ACER Down on Regulatory News & More

Added to Collection on: 2022-06-22 16:57:42

Tags for this article:

Clinical trials
COVID-19 vaccination in the United States
RNA vaccines
Health
Life Sciences
Food and Drug Administration
Medical research
Moderna COVID-19 vaccine
Pfizer-BioNTech COVID-19 vaccine
Relief Therapeutics
Moderna
Emergency use authorization

Click the tags to see associated articles and topics

View Article Details
FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup ... - PR Newswire

Added to Collection on: 2022-07-01 13:47:57

Tags for this article:

Life Sciences
Health sciences
Drugs
Antidepressants
Cycloserine/lurasidone
Aviptadil
Novartis
Pfizer
Nrx
Remdesivir
Food and Drug Administration
Relief Therapeutics
NRx Pharmaceuticals, Inc.

Click the tags to see associated articles and topics

View Article Details
Peptide Therapeutics Market worth $69.56 billion by 2030, - openPR.com

Added to Collection on: 2024-02-27 15:33:35

Tags for this article:

PEPTIDE THERAPEUTICS
Peptides
Relief Therapeutics
Zealand Pharma
Eli Lilly and Company
Peptide
Roche
C-peptide
360iResearch.com

Click the tags to see associated articles and topics

View Article Details